CHECKMATE 647: A PHASE 2, OPEN-LABEL STUDY OF NIVOLUMAB IN...

Hematological Oncology 2017 / 06 Vol. 35

CHECKMATE 647: A PHASE 2, OPEN-LABEL STUDY OF NIVOLUMAB IN RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA OR RELAPSED/REFRACTORY PRIMARY TESTICULAR LYMPHOMA

Nayak, L., Iwamoto, F.M., Ferreri, A.J., Santoro, A., Singer, S., Batlevi, C., Batchelor, T., Rubenstein, J., Johnston, P., Ramchandren, R., Soussain, C., Drappatz, J., Becker, K., Witzens-Harig, M.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2440_2
Date:
June, 2017
File:
PDF, 84 KB
english, 2017
Conversion to is in progress
Conversion to is failed